BioXcel Therapeutics, Inc. (BTAI) Social Stream
BIOXCEL THERAPEUTICS INC (BTAI) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering BTAI.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 6 | $140 | $75 | $101.375 | $2.68 | 3682.65% |
| 2021-12-16 | 7 | $140 | $75 | $101.375 | $2.68 | 3682.65% |
| 2022-01-13 | 7 | $140 | $73 | $99.75 | $2.68 | 3622.01% |
| 2022-02-01 | 7 | $140 | $73 | $99.428 | $2.68 | 3610% |
| 2022-03-10 | 6 | $140 | $73 | $99.428 | $2.68 | 3610% |
| 2022-03-18 | 6 | $130 | $73 | $98.5 | $2.68 | 3575.37% |
| 2022-04-06 | 5 | $130 | $73 | $98.5 | $2.68 | 3575.37% |
| 2022-04-08 | 4 | $130 | $76 | $101.5 | $2.68 | 3687.31% |
| 2022-04-14 | 4 | $134 | $76 | $102.166 | $2.68 | 3712.16% |
| 2022-04-25 | 4 | $134 | $76 | $101.833 | $2.68 | 3699.74% |
| 2022-05-09 | 4 | $134 | $62 | $90.5 | $2.68 | 3276.87% |
| 2022-05-10 | 4 | $134 | $20 | $81.166 | $2.68 | 2928.58% |
| 2022-05-13 | 4 | $134 | $20 | $76.571 | $2.68 | 2757.13% |
| 2022-05-23 | 4 | $110 | $20 | $73.142 | $2.68 | 2629.18% |
| 2022-06-08 | 4 | $110 | $20 | $71.714 | $2.68 | 2575.9% |
| 2022-07-07 | 5 | $110 | $19 | $62.428 | $2.68 | 2229.4% |
| 2022-08-13 | 5 | $110 | $19 | $61.571 | $2.68 | 2197.43% |
| 2022-09-17 | 5 | $90 | $19 | $58 | $2.68 | 2064.18% |
| 2022-11-16 | 7 | $85 | $18 | $52.625 | $2.68 | 1863.62% |
| 2022-12-01 | 8 | $85 | $16 | $48.555 | $2.68 | 1711.75% |
| 2022-12-15 | 8 | $85 | $16 | $49.222 | $2.68 | 1736.64% |
| 2023-01-03 | 8 | $82 | $16 | $47.888 | $2.68 | 1686.87% |
| 2023-01-26 | 8 | $82 | $20 | $49 | $2.68 | 1728.36% |
| 2023-01-30 | 8 | $78 | $20 | $48.555 | $2.68 | 1711.75% |
| 2023-02-08 | 8 | $78 | $20 | $48.777 | $2.68 | 1720.04% |
| 2023-02-21 | 8 | $79 | $20 | $51 | $2.68 | 1802.99% |
| 2023-03-09 | 8 | $79 | $20 | $51 | $2.68 | 1802.99% |
| 2023-03-10 | 8 | $79 | $22 | $51.222 | $2.68 | 1811.27% |
| 2023-03-21 | 8 | $78 | $22 | $49.666 | $2.68 | 1753.21% |
| 2023-03-31 | 8 | $75 | $22 | $49.333 | $2.68 | 1740.78% |
| 2023-05-08 | 8 | $75 | $22 | $49 | $2.68 | 1728.36% |
| 2023-05-10 | 8 | $75 | $22 | $51.444 | $2.68 | 1819.55% |
| 2023-05-11 | 8 | $75 | $24 | $51.666 | $2.68 | 1827.84% |
| 2023-06-06 | 8 | $75 | $24 | $51.555 | $2.68 | 1823.69% |
| 2023-06-29 | 8 | $75 | $23 | $49.333 | $2.68 | 1740.78% |
| 2023-07-03 | 8 | $75 | $23 | $48.666 | $2.68 | 1715.9% |
| 2023-07-05 | 8 | $75 | $18 | $43.444 | $2.68 | 1521.04% |
| 2023-08-14 | 8 | $75 | $18 | $43.444 | $2.68 | 1521.04% |
| 2023-08-15 | 8 | $60 | $4 | $25.111 | $2.68 | 836.98% |
| 2023-08-28 | 8 | $31 | $4 | $14.888 | $2.68 | 455.52% |
| 2023-11-15 | 8 | $24 | $4 | $12.875 | $2.68 | 380.41% |
| 2023-12-12 | 8 | $24 | $4 | $12.5 | $2.68 | 366.42% |
| 2023-12-15 | 7 | $18 | $4 | $10.857 | $2.68 | 305.11% |
The Trend in the Analyst Price Target
Over the past 43 months, BTAI's average price target has gone down $75.43.
Over the past 46 weeks, BTAI's average upside potential has been 234.23%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-04-05 | 8 | 75 | 22 | 49.000 | 17.06 | 187.22% |
| 2023-06-29 | 8 | 75 | 23 | 49.333 | 6.39 | 672.03% |
| 2023-10-17 | 8 | 24 | 4 | 12.875 | 2.90 | 343.97% |
| 2023-12-12 | 8 | 24 | 4 | 12.500 | 3.17 | 294.32% |
| 2023-12-15 | 7 | 18 | 4 | 10.857 | 3.24 | 235.09% |
BTAI Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.14 | 3 | 0 | 4 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
Over the past 35 weeks, BTAI's average broker recommendation rating worsened by 0.64.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BTAI as an investment opportunity.
- In terms of how BIOXCEL THERAPEUTICS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 4810.7% of that group.
- In the context of stocks in the small market cap category, BIOXCEL THERAPEUTICS INC's average analyst price target is greater than 4273.06% of them.
- In the context of stocks in the small market cap category, BIOXCEL THERAPEUTICS INC's variance in analysts' estimates is lower than -4031.27% of them.
- In the context of stocks in the small market cap category, BIOXCEL THERAPEUTICS INC's number of analysts covering the stock is higher than 3615.9% of them.
Stocks similar to BIOXCEL THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are IFRX, MBIO, and EOLS.
View All Top Stocks by Price Target
Is BTAI a Buy, Hold or Sell? See the POWR Ratings now!